Nanoparticle delivery system for ewing sarcoma treatment
Ended Cooperative Agreement Awarded Last action
- Award ID
- R41CA203457
- Recipient
-
Nanovalent Pharmaceuticals Inc. UEI NFPTYA1R6KY1
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $240,750
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Bozeman, MT, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $240,750 |
Quick answers
Who received award R41CA203457?
R41CA203457 was awarded to Nanovalent Pharmaceuticals Inc. by National Institutes of Health (Department of Health and Human Services) on April 15, 2016.
How much is award R41CA203457 worth?
$240,750 has been obligated on R41CA203457.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award